Arecaidine

Overview

Arecaidine is a GABA transport system inhibitor. Arecaidine inhibits the proliferation of oral mucosal fibroblasts, increases the secretion of IL-6 , TGF-β and TNF-α in cells, downregulates the expression of PPAR-γ and PCK1 in cells, and upregulates the expression of TGF-β1 . Arecaidine inhibits the uptake of γ-aminobutyric acid and β-alanine by the central nervous system of cats . Arecaidine inhibits hPAT1-mediated L-[ 3 H]proline uptake in cells. Arecaidine can be used in research related to neurological diseases.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Vitamin D Related/Nuclear Receptor | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > GABA Receptor | Products > Signaling Pathways > Interleukin Related | Products > Signaling Pathways > TGF-β Receptor | Products > Signaling Pathways > TNF Receptor | Products > Signaling Pathways > PPAR

Product Information

• Catalog No.: HY-N2368
• CAS No.: 499-04-7
• Molecular Formula: C7H11NO2
• Molecular Weight: 141.17
• Purity: 99.63%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: 100 mg/mL (708.37 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source